公益財団法人大原記念倉敷中央医療機構 倉敷中央病院は、岡山県倉敷市美和にある公益法人の病院。発行する文書で使用する略称は倉中もしくはKCH。

During the past decade, Kurashiki Central Hospital conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 19 clinical trials were completed, i.e. on average, 39.6% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 15 clinical trials were completed. i.e. 57.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kurashiki Central Hospital" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Bayer" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kurashiki Central Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Kurashiki Central Hospital" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Medtronic Japan Co., Ltd." with 2 trials as a collaborator and "Nagoya University" with 2 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Kurashiki Central Hospital" are "Coronary Artery Disease" (6 trials), "Myocardial Ischemia" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Non-Small Cell Lung Cancer" (3 trials) and "Psoriasis" (3 trials). Many other conditions were trialed in "Kurashiki Central Hospital" in a lesser frequency.

Most popular intervention types in "Kurashiki Central Hospital" are "Drug" (41 trials), "Device" (17 trials), "Other" (5 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cisplatin" (5 trials), "Pemetrexed" (5 trials), "BMS-986165" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kurashiki Central Hospital" are 64 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Kurashiki Central Hospital". undefined are not yet recruiting, 14 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Kurashiki Central Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kurashiki Central Hospital, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".